Washington University School of Medicine, St Louis, MO 63108, USA.
Phys Ther. 2011 Jun;91(6):923-30. doi: 10.2522/ptj.20100329. Epub 2011 Apr 7.
Increased lipid accumulation in skeletal muscle has been linked to insulin resistance, impaired muscle performance, and impaired physical function. It is unclear whether physical activity is associated with lipid content in skeletal muscle, muscle performance, or overall physical function.
The purpose of this study was to characterize physical activity levels (average daily step count) in a sample of people with diabetes and peripheral neuropathy and to determine the relationship among step count, intermuscular adipose tissue volume (IMAT), muscle performance (peak torque, power), and physical function.
A cross-sectional design was used in this study.
Twenty-two people with diabetes and peripheral neuropathy (15 men and 7 women, mean age=64.5 years [SD=12.7], and mean body mass index=33.2 kg/m(2) [SD=6.4]) participated. Average daily step count, glycosylated hemoglobin, modified 9-item Physical Performance Test scores, Six-Minute Walk Test distance, calf intermuscular adipose tissue volume (via magnetic resonance imaging), and isokinetic dynamometry of the ankle muscles were recorded.
Average daily step count was 7,754 (SD=4,678; range=3,088-20,079). Five participants had an average daily step count greater than 10,000. Average IMAT volume was 84 cm(3) (SD=88). Greater average daily step count was associated with younger age (r=-.39, P<.05) and with lower IMAT volume in the calf (r=-.44, P<.05). Lower IMAT volume was associated with greater muscle performance (r=-.45) and physical function (r=-.43 to -.48).
The sample in this study may be biased toward people with high levels of activity because participants were recruited for an exercise study. The results should not be generalized to people taking fewer than 3,000 steps/day or to those with a current foot ulcer, peripheral arterial disease, or severe foot deformity or amputation or who weigh more than 136 kg (300 lb).
Average daily step count was inversely related to IMAT, and IMAT was inversely related to muscle performance and overall physical function. In addition, we found that people with diabetes and peripheral neuropathy and without severe foot deformity appear to be able to take a large number of steps per day.
骨骼肌中脂质积累的增加与胰岛素抵抗、肌肉性能受损和身体功能下降有关。目前尚不清楚体力活动是否与骨骼肌中的脂质含量、肌肉性能或整体身体功能有关。
本研究的目的是描述糖尿病合并周围神经病变患者的体力活动水平(平均每日步数),并确定步数与肌间脂肪组织体积(IMAT)、肌肉性能(峰值扭矩、功率)和身体功能之间的关系。
本研究采用横断面设计。
22 名糖尿病合并周围神经病变患者(15 名男性,7 名女性,平均年龄 64.5 岁[标准差 12.7],平均体重指数 33.2 kg/m2[标准差 6.4])参与了本研究。记录平均每日步数、糖化血红蛋白、改良的 9 项身体表现测试评分、6 分钟步行测试距离、小腿肌间脂肪组织体积(通过磁共振成像)和踝关节肌肉等速测力。
平均每日步数为 7754 步(标准差 4678 步;范围 3088-20079 步)。有 5 名参与者的平均每日步数超过 10000 步。平均 IMAT 体积为 84cm3(标准差 88cm3)。平均每日步数较多与年龄较小(r=-.39,P<.05)和小腿 IMAT 体积较低(r=-.44,P<.05)有关。较低的 IMAT 体积与更好的肌肉性能(r=-.45)和身体功能(r=-.43 至-.48)有关。
由于参与者是为一项运动研究而招募的,因此本研究中的样本可能偏向于活动水平较高的人群。研究结果不能推广到每天步数少于 3000 步的人群,或目前有足部溃疡、外周动脉疾病或严重足部畸形或截肢或体重超过 136kg(300 磅)的人群。
平均每日步数与 IMAT 呈负相关,而 IMAT 与肌肉性能和整体身体功能呈负相关。此外,我们发现没有严重足部畸形的糖尿病合并周围神经病变患者每天似乎可以走很多步。